Home›Compare›MangoRx vs Miiskin

MangoRx vs Miiskin: Which Is Better?

Head-to-head comparison of MangoRx and Miiskin based on our independent scoring across trust, value, experience, product range, and reputation — plus real pricing for the treatments they both offer.

Our Verdict

Miiskin scores higher overall in our independent evaluation (68.7/100 vs 58/100), leading on trust & safety, value, experience, reputation. MangoRx comes out ahead on product range.

58

MangoRx is the Dallas-based men's health telehealth brand of Nasdaq-listed Mangoceuticals, selling compounded ED, hair-loss and oral semaglutide products alongside injectable and oral (Kyzatrex) testosterone.

Visit MangoRx
69

Miiskin is a Copenhagen-founded asynchronous teledermatology platform where US patients pick an independent board-certified dermatologist for a $59–69 photo consult covering acne, rosacea, eczema, hair loss and 30+ other conditions.

Visit Miiskin

Score Breakdown

DimensionMangoRxMiiskin
Overall Score58/10068.7/100 ✓
Trust & Safety30%55/10072/100 ✓
Value25%62/10074/100 ✓
Experience20%58/10070/100 ✓
Product Range15%66/100 ✓56/100
Reputation10%45/10062/100 ✓

At a Glance

Founded20212015
HeadquartersDallas, TXCopenhagen, Denmark
Publicly tradedYes (MGRX)No
Treatment categories52
Treatments listed54
Starting price$50/mo$48.99/mo

Pricing Where They Compete

Prices shown are based on our most recent research and may not reflect current pricing. Telehealth providers update their pricing frequently. Always verify pricing directly with the provider before purchasing.

CategoryMangoRxMiiskin
Hair Loss$50–$80
Grow (compounded hair-loss formula)
$59–$69
Hair Loss (finasteride/minoxidil)

MangoRx

+Injectable TRT program priced at $99/month with doctor visits, lab work and medication included (per February 2026 company release and current site listing)
+Offers a branded FDA-approved oral testosterone option (Kyzatrex-based 'Prime') alongside compounded injectable TRT, which few small men's-health platforms carry
+Public-company SEC disclosures make ownership, pharmacy relationships and finances unusually visible for a brand this size
−Going-concern risk: $228,688 cash on hand at June 30, 2026 against a six-month net loss of $4.7M, per its Q2 2026 10-Q
−Compounded products are filled by Epiq Scripts, a pharmacy majority-owned (52%) by the CEO, a related-party arrangement
−Very small patient base: Q2 2026 revenue of $68,757, down 59% year over year, and only 18 Trustpilot reviews
Read the full MangoRx review →

Miiskin

+Every consult is handled by a named, board-certified dermatologist whom the patient chooses, and the same doctor handles follow-ups
+Pricing is published: $59–69 new consult, $39 renewal, custom formulas $48.99–68.99
+Publishes response times (14.4-hour average, April–June 2026) instead of only a marketing promise
−Small dermatologist network; only two network dermatologists can prescribe isotretinoin
−Miiskin doesn't employ the dermatologists or practice medicine, so clinical accountability sits with independent providers
−Custom formulas are compounded (Foothills Pharmacy) and not FDA-reviewed for safety or efficacy
Read the full Miiskin review →

MangoRx vs Miiskin — FAQ

Is MangoRx better than Miiskin?

▾

Miiskin scores higher overall in our independent evaluation (68.7/100 vs 58/100), leading on trust & safety, value, experience, reputation. MangoRx comes out ahead on product range.

Is MangoRx or Miiskin cheaper?

▾

Miiskin has the lower starting price (from $48.99/mo vs $50/mo for MangoRx). Starting prices are for the cheapest treatment each offers — compare the specific treatment you need, and check what each price includes.

What do MangoRx and Miiskin both offer?

▾

Both platforms treat Hair Loss. MangoRx covers 5 treatment categories total and Miiskin covers 2.

Still deciding?

MangoRx alternativesMiiskin alternativesTake the Match Quiz